Opendata, web and dolomites
H2020 projects about "therapeutics"
The page lists 256 projects related to the topic "therapeutics".
| # | |||
|---|---|---|---|
| 1 | DOLORisk | DOLORisk: Understanding risk factors and determinants for neuropathic pain | 2015 |
| 2 | NanoChemBioVision | Next Generation Label-free Chemical Nanoscopy for Biomedical Applications | 2015 |
| 3 | EPIMAC | The next generation epigenetic medicine for inflammation | 2015 |
| 4 | NABBA | Design and development of advanced NAnomedicines to overcome Biological BArriers and to treat severe diseases | 2015 |
| 5 | TOLLerant | Toll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach. | 2015 |
| 6 | MetaRNA | RNA-based technologies for single-cell metabolite analysis | 2015 |
| 7 | ENATRANS | Enabling NAnomedicine TRANSlation | 2015 |
| 8 | TUSUPO | Tubular Supramolecular Polymers: A new class of therapeutic polymers | 2015 |
| 9 | GLYCO-TOOLS | Bio-Inspired Tools for Glycoscience | 2015 |
| 10 | ISOTRAPSS | Isoform specific inhibition by transient protein state stabilization | 2015 |
| 11 | PoreSelect | Macroporous Polymer Monoliths as a Low-Cost Bioanalytical Platform for Biopharmaceutical Glycoprotein | 2016 |
| 12 | TRANSFORMER | Transformation of emerging contaminants in the aquatic environment. Fate of transformation products under multiple stress conditions | 2015 |
| 13 | NANOCARB | Self-selection of a multivalent nanosystem for carbohydrate recognition | 2015 |
| 14 | WORMTUMORS | Worm power: Can helminths modify the development of colorectal cancer? | 2015 |
| 15 | Micropod | MICROPOrous Devices for next-generation therapeutic delivery | 2015 |
| 16 | Subpopulations | Investigating Fibrotic and Regenerative Fibroblast Populations in Muscular Dystrophy | 2016 |
| 17 | CR-PHAGOCYTOSIS | Complement-mediated phagocytosis in neutrophils | 2015 |
| 18 | NEWCARBOVAX | New generation of carbohydrate-based vaccines via rational understanding of their immunological mechanism | 2017 |
| 19 | Protprot | Biophysical characterisation of a protein-activating protein-protein interaction | 2015 |
| 20 | BIOINOHYB | Smart Bioinorganic Hybrids for Nanomedicine | 2016 |
| 21 | NanoCytox | Development of Novel Analytical Methods to assess Nanoparticle cytotoxicity | 2015 |
| 22 | MetCAF | Uncovering the Role of Cancer Associated Fibroblasts in Facilitating Breast Cancer Metastasis | 2015 |
| 23 | CilDyn | Molecular analysis of the Hedgehog signal transduction complex in the primary cilium | 2015 |
| 24 | Novel asthma therapy | Biocompatible nanoparticles for T cell targeted siRNA delivery as novel asthma therapy | 2015 |
| 25 | SIRENE | Silencing miR-199b to attenuate the progression of heart failure. | 2015 |
| 26 | ProteinConjugates | A training network for the chemical site-selective modification of proteins: Preparation of the next-generation of therapeutic chemically-defined protein conjugates | 2015 |
| 27 | BtRAIN | Brain barriers training | 2015 |
| 28 | PROFILE | Innovative training network: Immunoprofile-directed stratification of patients with the autoimmune disorder thrombotic thrombocytopenic purpura | 2015 |
| 29 | IonoChem | IonoChem: A new and highly efficient cross membrane drug delivery strategy | 2015 |
| 30 | LeukoTheranostics | Harnessing Targeted Nanotheranostics to Reprogram Activated Leukocytes in Inflammatory Bowel Disease | 2015 |
| 31 | Biomarkers for PD | Validation of diagnostic and prognostic biomarkers for Parkinson disease | 2015 |
| 32 | STEMCARDIORISK | Stem Cells for Cardiac Arrhythmia Risk Assessment | 2015 |
| 33 | PRION2020 | Function and malfunction of the prion protein | 2015 |
| 34 | PROSEQO | PROtein SEQuencing using Optical single molecule real-time detection | 2016 |
| 35 | F-CCW | Functional Cell Culture Ware (F-CCW) : Technical and Commercial feasible? | 2015 |
| 36 | MAIN | Molecular Adhesion and Interactions in the Nervous system | 2016 |
| 37 | SWEETOOLS | Smart Biologics: Developing New Tools in Glycobiology | 2016 |
| 38 | REGENETHER | Modeling and treating retinal degenerative disease | 2015 |
| 39 | T2DSystems | Development of a systems biomedicine approach for risk identification, prevention and treatment of type 2 diabetes | 2016 |
| 40 | COSYN | Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders | 2016 |
| 41 | EvoGenMed | Evolutionary genomics: new perspectives and novel medical applications | 2016 |
| 42 | EPIC | Exploiting Protein Complexes that Induce Cell-death | 2016 |
| 43 | BISON | BrIdging Structural BiOlogy with Biological SyNthesis and Self Assembly to Reveal Key Processes in Living Systems | 2016 |
| 44 | Gene2Skin | Gene2Skin - Roadmap for advanced genetic engineering-based skin therapies | 2015 |
| 45 | PAPAstudy | Podocyte Adaptation Proliferation and Ageing | 2016 |
| 46 | MCTRinIA | Resolution Pharmacology and Physiology of MCTR in Arthritis | 2016 |
| 47 | RespMicroFlows | Unravelling respiratory microflows in silico and in vitro: novel paths for targeted pulmonary delivery in infants and young children | 2016 |
| 48 | DIALOY | Mosaic loss of chromosome Y (LOY) in blood cells - a new biomarker for risk of cancer and Alzheimer’s disease in men | 2016 |
| 49 | CollBioImag | Development of a cell-based system for high-throughput screening of antifibrotics | 2016 |
| 50 | SmartCubes | An innovative class of nanoparticles (“SmartCubes”) for the targeted delivery of protein therapeutics | 2016 |
| 51 | PYANO | Retargeted Pyocins: A novel tool for combating major food borne pathogens and exploitingphage-host interactions | 2016 |
| 52 | NanoCap | Sustainable Polypeptide Nanoparticle Platform for Drug Delivery | 2016 |
| 53 | ADHERE | Aptamer nanostructures dual-targeted to the HER receptor family for cancer therapy | 2016 |
| 54 | THERAGEL | Development of a chemotherapeutic gel for glioblastoma multiforme treatment | 2016 |
| 55 | GallBiome | Characterization of the Human Gallbladder Microbiome | 2016 |
| 56 | BiCyHePepDi | Bicyclic hetero peptidimer - a novel molecule format for therapeutic peptides | 2016 |
| 57 | CureCKDHeart | Targeting perivascular myofibroblast progenitors to treat cardiac fibrosis and heart failure in chronic kidney disease | 2016 |
| 58 | ONCOINTRABODY | Targeting common oncogenes with intracellular monobodies | 2016 |
| 59 | EpiHope | Epigenetic biomarkers for prediction of vascular complications and response to treatment in subjects with diabetes | 2016 |
| 60 | Ubl-Code | Revealing the ubiquitin and ubiquitin-like modification landscape in health and disease | 2016 |
| 61 | RAMBO | Mitochondrial DNA degradation and sterile inflammation in the heart | 2016 |
| 62 | Relieve-Chol | Reprogramming cell identity to develop new therapies against Cholangiopathies | 2016 |
| 63 | iPSCAtaxia | An induced pluripotent stem cell-based neuronal model of Spinocerebellar ataxia | 2016 |
| 64 | AD-VIP | Alzheimer’s disease and AAV9: Use of a virus-based delivery system for vectored immunoprophylaxis in dementia. | 2016 |
| 65 | REDOXDRUGS | Discovery and commercialisation of novel compounds targeting redox proteins | 2016 |
| 66 | TRACT | Training in Cancer Mechanisms and Therapeutics | 2016 |
| 67 | ALZSYN | Imaging synaptic contributors to dementia | 2016 |
| 68 | RADoTE | Remote-Activated Delivery of Therapeutic Exosomes (RADoTE) via an Injectable PEG Hydrogel Carrier | 2016 |
| 69 | INSPIRED | Targeting IRE1 in disease | 2017 |
| 70 | 3D NEONET | Drug Discovery and Delivery NEtwork for ONcology and Eye Therapeutics | 2017 |
| 71 | CUPIDO | Cardio Ultraefficient nanoParticles for Inhalation of Drug prOducts | 2017 |
| 72 | GUTPEPTIDES | Novel therapeutic approaches to improve gastrointestinal wound healing | 2017 |
| 73 | MAGNAMED | Novel magnetic nanostructures for medical applications | 2017 |
| 74 | EuroNanoMed III | ERA-NET ON NANOMEDICINE | 2016 |
| 75 | SLaMM | Magnetic Solid Lipid Nanoparticles as a Multifunctional Platform against Glioblastoma Multiforme | 2017 |
| 76 | TEN-COMPLEX | Teneurin interactions in the neuronal synapse | 2017 |
| 77 | MetResistance | The role of tumour microenvironment in metastatic hormone-refractory prostate cancer | 2017 |
| 78 | Bronchomycn | First in class epithelial Barrier-enhancing medicine for respiratory diseases | 2017 |
| 79 | COLGENES | Defining novel mechanisms critical for colorectal tumourigenesis | 2017 |
| 80 | GAIT | From symptom relief to disease modifying allergy treatment with Glycan-Allergen Immunotherapy | 2017 |
| 81 | PANTREAT | Pancreatic cancer as a treatment target of Dwarfbody-Therapeutics | 2017 |
| 82 | CARBOFLU | Chemoenzymatic synthesis of complex glycans to decipher the interactions between them and Influenza A virus | 2017 |
| 83 | BioMPCat | Bioorthogonal Metal-Peptide Catalysis | 2017 |
| 84 | FLUDD | Late Stage Fluorination and its Applications to Drug Discovery | 2017 |
| 85 | CoALIVE | Coenzyme A – Launch of In Vivo Experiments | 2017 |
| 86 | RepliStressTiming | Impact of replicative stress on DNA replication timing control | 2017 |
| 87 | ExoSensor | A Nano-photoelectric Exosome Biosensor for Point-of-care Diagnosis of Early-stage Cancer | 2017 |
| 88 | REVERSING TAUOPATHY | Identifying and deciphering the mechanism of the cellular machinery responsible for disaggregation of intracellular prion-like Tau aggregates | 2017 |
| 89 | IMMUNO_CRC | Microbiota-immune interaction in colorectal cancer | 2017 |
| 90 | RHOMBOSMALPS | Enabling malaria rhomboid proteases as drug targets: usage of molecular cookie cutters to shape novel activity assays and inhibitors. | 2017 |
| 91 | MitoDyaD | The role of the glucocorticoid receptor in dopaminoceptive neurons in mitochondrial dysfunction and vulnerability to depression | 2017 |
| 92 | RNAatHD | Development of a high-resolution method to monitor structural changes of regulatory RNAs and therapeutic oligo-nucleotides directly in-cell. | 2017 |
| 93 | Glyco-Platforms | Novel smart glyco-nanomaterials as targeted therapeutics. | 2017 |
| 94 | RTKPalm | Modulating and Profiling Receptor Tyrosine Kinase S-palmitoylation in Breast Cancer | 2017 |
| 95 | MOOAC | Multi-compartmental Organ-on-a-Chip | 2018 |
| 96 | RESCEU | REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019 | 2017 |
| 97 | NanoPD | Single Molecule Nanoscale Sensors for Improved Therapies and Diagnostics | 2017 |
| 98 | STORM | Signal Transduction in Organic Materials | 2017 |
| 99 | EASY | Epigenetic approach for the treatment of obesity | 2017 |
| 100 | ZECARDIO | Cardiotoxicity High-throughput screening (HTS) with zebrafish embryo | 2017 |
| 101 | NEST | Nanoengineering of radioactive seeds for cancer therapy and diagnosis | 2017 |
| 102 | altEJrepair | Characterisation of DNA Double-Strand Break Repair by Alternative End-Joining: Potential Targets for Cancer Therapy | 2017 |
| 103 | GENDOSIS | GENOTYPE - ENDOPHENOTYPE ASSOCIATIONS IN PSYCHOSIS | 2017 |
| 104 | CyberGenetics | Cybergenetics: Theory and Design Tools for Biomolecular Control Systems | 2017 |
| 105 | iEBDD | A Software Interface for Interactive Ensemble-Based Drug Design | 2017 |
| 106 | NOVITREP | Novel viral therapy through targeting DNA repair | 2017 |
| 107 | PeptIn | employing protein aggregation as an antibacterial design strategy | 2017 |
| 108 | iDESIGN | Delivering Better Starting Points for Drug Discovery: New Compound Libraries Driven By Intelligent Design | 2018 |
| 109 | NeuroQure | Neuroprotective human antibodies to the flexible tail of the prion protein | 2017 |
| 110 | NANOSTEM | New nanomaterials for neural stem cells drug delivery | 2018 |
| 111 | MalPar.NET | Malaria Parasite Networking: Discovering Modes of Cell-Cell Communication | 2017 |
| 112 | VIRO-FLOW | Enabling Technologies and Drug Discovery: Continuous Flow Processes to Discover Novel Antiviral Inhibitors | 2017 |
| 113 | SUGARSmart | SUGARSmart: Smart design of recombinant antibody fragments specific for carbohydrate molecules | 2018 |
| 114 | New Chol | Development of New therapies against cholangiopathies. | 2017 |
| 115 | R-LiNK | Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative | 2018 |
| 116 | BioMatrix | Structural Biology of Exopolysaccharide Secretion in Bacterial Biofilms | 2018 |
| 117 | MATADOR | MAmmary chemoresistant Tumor deAth by Directed cell ORientation | 2018 |
| 118 | INTACT | Imaging NM: A Nanoparticulate Precision Medicine Approach to Target Cancer | 2017 |
| 119 | ImmuneHunter | Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneously | 2017 |
| 120 | XHaLe | Hanover experimental lung research project | 2018 |
| 121 | DrBox | eHealth platform to assess patient clinical progress due to prescribed medication | 2018 |
| 122 | inhibitAUTO | Towards a New Frontier in Autophagy Inhibition: The Development of a Novel Class of ChemicalProbes and Identification of Their Associated Biological Target | 2018 |
| 123 | BESIDE | Bile acids and epithelial stem cells in intestinal development | 2018 |
| 124 | BREFMC2017 | Deciphering the function(s) of the C-type lectin DCIR/CLEC4A in tuberculosis | 2018 |
| 125 | CENTR-ALL | Clarifying role of the CENTROSOME in abnormal mitotic processes featuring the most commonchildhood malignancy: paediatric High Hyperdiploid Acute Lymphoblastic Leukaemia (HHDpALL) | 2019 |
| 126 | MuSeq | Defining the Oligodendrocyte Lineage in Multiple Sclerosis Lesions by Single Cell RNA-Sequencing | 2018 |
| 127 | TheraSonix | Ultrasonic Imaging and Drug Propulsion Into Tumors Using Genetically Encoded Gas Nanostructures | 2018 |
| 128 | RNAmpMax | Maximization of amplification of next-generation RNA replicon vaccines through synergistic molecular and formulation design | 2019 |
| 129 | NEUROTARGET | Treatment of traumatic brain injury using dye-loaded polymeric nanoparticles | 2018 |
| 130 | UNNAMEd-2 | Unraveling the conceptional novel ADAM17 regulation by PP2A in metastasis formation. | 2019 |
| 131 | HDAC6_GEMM | Development of a novel genetically engineered mouse model to study the role of HDAC6 in oncogenesis and metastasis of non-small cell lung cancer. | 2018 |
| 132 | TakeupSLaCk | Role and regulation of dendritic cell functions by Solute Carrier Transporters | 2019 |
| 133 | MechaDynA | Multi-scale mechanics of dynamic leukocyte adhesion | 2018 |
| 134 | BIORECAR | Direct cell reprogramming therapy in myocardial regeneration through an engineered multifunctional platform integrating biochemical instructive cues | 2018 |
| 135 | ElectroGene | Electrogenetics – Shaping Electrogenetic Interfaces for Closed-Loop Voltage-Controlled Gene Expression | 2018 |
| 136 | CERVINO | Can human embryo-released extracellular vesicles govern endometrial receptivity and inform on vanguard embryo diagnostics and fertility therapeutics? | 2018 |
| 137 | DYNACOTINE | Signal transduction and allosteric modulation of nicotinic acetylcholine receptors:from ion channel electrophysiology to atomic 3D structures | 2019 |
| 138 | BIOCOPY | BIOCOPY: the new biomolecule copying and screening solution for diagnostics and therapeutics | 2018 |
| 139 | EpiGlioT | Epigenetic Glioblastoma Therapeutics | 2018 |
| 140 | PAH-HOPE | New hope for the PAH patient: A Novel Therapeutic for Pulmonary Arterial Hypertension (PAH) | 2018 |
| 141 | PICARD | Disruptive GPCR Lead Discovery Platform Delivering New and Safer Therapeutics | 2018 |
| 142 | StayAble | A non-surgical and long-lasting treatment to substantially reduce back pain | 2018 |
| 143 | SenolT | Fast and effective diagnostic test for the early detection of residual tumours to prevent cancer recurrence | 2018 |
| 144 | SWIRL | Short, weakly interacting RNA ligands for the development of high-concentration monoclonal antibody therapeutics | 2018 |
| 145 | SIGNIA | SIGNIA: An innovative drug discovery platform for rapid identification and validation of antimicrobial applications in available pharmaceutical resources and drugs open for repurposing. | 2018 |
| 146 | RenalToolBox | Developing novel tools and technologies to assess the safety and efficacy of cell-based regenerative medicine therapies, focusing on kidney disease | 2018 |
| 147 | SOMIT | Leveraging a novel platform technology to develop a first-in-class immunotherapy for Celiac Disease | 2018 |
| 148 | NanoCarb | Glyco-Nanoparticles for Applications in Advance Nanomedicine | 2018 |
| 149 | CereBrill | Brain training tools for better focus - using games and brainwaves to improve performance in children with ADHD | 2018 |
| 150 | BestTreat | BestTreat – Building a Gut Microbiome Engineering Toolbox for In-Situ Therapeutic Treatments for Non-alcoholic Fatty Liver Disease | 2018 |
| 151 | RxmiRcanceR | Tumor suppressive microRNAs for cancer therapy | 2018 |
| 152 | INTEGRATA | Integrating chemical and biological approaches to target NAD production and signaling in cancer | 2018 |
| 153 | MetaboliQs | Leveraging room temperature diamond quantum dynamics to enable safe, first-of-its-kind, multimodal cardiac imaging | 2018 |
| 154 | VIRUSES AND RNA | RNA regulation during viral infection | 2019 |
| 155 | PROPHECY | Translational control in infection biology: riboproteogenomics of bacterial pathogens | 2018 |
| 156 | StarT | European Training Network to Diagnose, Understand and Treat Stargardt Disease, a Frequent Inherited Blinding Disorder | 2018 |
| 157 | CONNECT | Connecting neural networks: Nervous-system-on-Chip Technology | 2019 |
| 158 | NanoMed-CKD | Feasibility of mCura1: A kidney-targeted nanomedicine that promotes self-healing of Chronic Kidney Disease with messenger RNA. | 2018 |
| 159 | LIPOBITS | Liposome-based Biomimetic Treatment for auto-immune diabetes (T1D) | 2018 |
| 160 | EVERBONE | Mechano-activated Extracellular Vesicle Based Repair of Bone | 2019 |
| 161 | CONQR | Translation and Commercialization of a QSOX1-inhibitory Antibody Targeting the Tumor Microenvironment in Breast Cancer | 2018 |
| 162 | ENDOSCAPE | ENDOSCAPE, a clinically applicable non-viral gene delivery technology | 2019 |
| 163 | Notid | Novel Target for Treatment of Chronic Inflammatory Diseases | 2018 |
| 164 | CuRE | Cardiac REgeneration from within | 2019 |
| 165 | NUMA-SCALE | Enabling Large-Scale GMP-ready Peptide Production with a new, reliable and cost-efficient Bioprocess | 2018 |
| 166 | POLYMMUNE | Off-the-Shelf Polypeptide-based Immunotherapy for Advanced Melanoma Treatment | 2019 |
| 167 | IM2PACT | Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain | 2019 |
| 168 | MIAMi | Refactoring monoterpenoid indole alkaloid production in microbial cell factories | 2019 |
| 169 | LIMBo | Zooming the link between diet and brain health: how phenolic metabolites modulate brain inflammation | 2019 |
| 170 | Homo.symbiosus | Assessing, preserving and restoring man-microbes symbiosis | 2019 |
| 171 | Neurovulnerability | Molecular mechanisms underlying selective neuronal death in motor neuron diseases | 2019 |
| 172 | TopSpec | Next generation precision antibody profiling - from science fiction to reality | 2019 |
| 173 | SEPSCAV | SCAVENGING ON SEPSIS. DEVELOPMENT OF SEPSIS SPECIFIC DRUGS FROM HUMAN SCAVENGER RECEPTORS | 2019 |
| 174 | TALE | Therapeutic Allele Engineering: A novel technology for cell therapy | 2019 |
| 175 | ProMiDis | A unified drug discovery platform for protein misfolding diseases | 2019 |
| 176 | OrganoPlate Graft | Organ-on-a-Chip technology for in vitro grafting and vascularisation of 3D tissues | 2019 |
| 177 | HAIKU | A breakthrough alternative to antibiotics for preventing and curing infectious diseases at Intensive Care Units | 2018 |
| 178 | ViR | We are developing ground-breaking therapeutics to cure currently untreatable respiratory infections affecting children and the elderly | 2019 |
| 179 | TraffikGene | Peptide Dynamic Amphiphiles for Gene Therapy and Macromolecular Delivery | 2019 |
| 180 | 20SInhibitor | Selective 20S proteasome inhibition for multiple myeloma therapy | 2019 |
| 181 | RGD-Diabetes | Development of RGD-therapeutics for cardio-metabolic disease | 2019 |
| 182 | Biosensor Design | Engineering Chemotactic Biosensors for a Diverse Spectrum of Metastatic Markers | 2020 |
| 183 | INHuMAN | Intra-tumoral heterogeneity in NRAS-driven metastatic melanoma | 2019 |
| 184 | CVD_CysSSSCys | Investigating the Therapeutic Potential of Persulfides: Implications of their Roles in Cardiovascular Disease | 2019 |
| 185 | R-FunSel | In vivo functional screening via CRISPR-Cas9 to systematically identify cardiomyocyte receptors as targets for the innovative therapies for myocardial infarction and heart failure | 2019 |
| 186 | TaPPiNG-EPI | Targeting Purinergic Pathway in drug-resistant epilepsy using human Neurons and Glia. | 2019 |
| 187 | CM_GF | Biological relevance of the multiple infection unit as a novel target for antiviral development | 2020 |
| 188 | REBELLION | Light-REsponsive Nanomachines for Targeted Eradication of BactErial Pathogens in LocaLised InfectIONs | 2020 |
| 189 | BIOMAP | Biomarkers in Atopic Dermatitis and Psoriasis | 2019 |
| 190 | TRAIN-HEART | TRAIN-HEART | 2019 |
| 191 | DECOMPACT | Development of Collagenase Polymeric nanocapsules as Therapeutics | 2019 |
| 192 | NSFTA | New Strategies For Therapeutic Antibodies – Synthetic bispecific antibodies & Antibody-Drug Conjugates with controlled drug loading. General methods for unexplored ADCs and personalised therapies. | 2020 |
| 193 | ProDelivery | High Throughput Synthesis of Polymeric Vesicles for Protein Delivery | 2019 |
| 194 | Lac-TB | Dissecting the impact of Lactate in Tuberculosis | 2020 |
| 195 | GOLDEN | Gold-Functionalized Devices and Engineered Nanoparticles: Bioorthogonal Tools for Unprecedented Biomedical Applications | 2019 |
| 196 | Grolaries | Cartilage progenitor cells for growth plate regeneration | 2019 |
| 197 | Tumor microbiome | The tumor microbial communities: Characterization, effects and translational opportunities | 2019 |
| 198 | SYNTISU | Remotely-controlled functional synthetic tissues | 2019 |
| 199 | microPhage | Automated microfluidic phage display through non-fouling droplet-based technologies | 2020 |
| 200 | TargetDUBs | Targeting ubiquitin processing in cancer and fibrosis: novel probes for the Ubiquitin Carboxy-Terminal Hydrolases | 2019 |
| 201 | FEN INHIBITORS | Development of Kinetoplastida Flap Endonuclease Inhibitors in Search for Novel Therapeutics | 2020 |
| 202 | TargetGBM | Generating a targeted, brain-permeable and stable polymeric nanoparticle for systemic gene delivery to glioblastoma | 2019 |
| 203 | RTTOPHAGY | """Investigating autophagy enhancement as a therapeutic approach for the treatment of Rett syndrome.""" | 2019 |
| 204 | RIVELIN-CLO | The Ultimate Therapy for the Oral Lichen Planus | 2019 |
| 205 | IBL-302 | Inflection Bioscience unique dual mechanism, small molecule, orally available therapeutic targeting major unmet medical needs in breast cancer | 2019 |
| 206 | SaPhaDe | Know your enemy: systematic discovery of Salmonella anti-Phage Defences for the improved design of phage therapeutics | 2019 |
| 207 | SPLITVAC | Harnessing the innate and adaptive immune system with targeted neoantigen based cancer vaccines | 2019 |
| 208 | 3DBrainStrom | Brain metastases: Deciphering tumor-stroma interactions in three dimensions for the rational design of nanomedicines | 2019 |
| 209 | Healthybiota | Microbiota-host interactions for integrative metabolic health reprogramming | 2019 |
| 210 | NETCONTROLOGY | Controllability of biological networks | 2020 |
| 211 | THIAZOLIUMenzyme | Enzyme design and engineering by implementation of non-canonical amino acids in protein scaffolds | 2019 |
| 212 | ARCAID | Amsterdam Rheumatology Center for AutoImmune Diseases | 2020 |
| 213 | BE Therapy | A revolutionary digital therapeutics platform for personalized and effective neurocognitive rehabilitation | 2019 |
| 214 | EXPERT | EXpanding Platforms for Efficacious mRNA Therapeutics | 2019 |
| 215 | MIBEst | Molecular Infection Biology Estonia - Research capacity building | 2019 |
| 216 | FRAME | FRAME - tumor genome-based personalized anti-cancer vaccines off-the-shelf | 2019 |
| 217 | TRACER | TRAF-STOP therapy to reduCe inflammation in athERosclerosis. | 2020 |
| 218 | II-LCA | Integrated Imaging in live Cell Analysis (II-LCA), for enhanced development and manufacturing of biologic and cell therapies. | 2019 |
| 219 | TranSYS | Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine | 2019 |
| 220 | BeatsDigTherapeutics | Project SCALE: Tailored Digital Therapeutics for Neurological and Brain Disorders | 2019 |
| 221 | LIVELMIA | Innovative assay for microRNAs analysis | 2019 |
| 222 | mRNA NanoDeli | Application of RNA nanotechnology for delivery of mRNA therapeutics | 2019 |
| 223 | NEUcrest | Training European Experts in Multiscale Studies of Neural Crest Development and Disorders: from Patient to Model Systems and Back again. | 2019 |
| 224 | StopAddict | The game changer drug to cure alcohol use disorders | 2019 |
| 225 | SLAM-Dx | Diagnostic drug response-profiling using SLAMseq | 2019 |
| 226 | TEXAD | TEXAD – Tailoring EXosomes for Autoimmune Diseases | 2019 |
| 227 | ADAMtx | ADAMtx: Development of Alzheimer’s immunotherapy by harnessing the natural reparative properties of microglia | 2019 |
| 228 | NANOCELL | A DNA NANOtechology toolkit for artificial CELL design | 2020 |
| 229 | CoEvolve | Deconstructing and rebuilding the evolution of cell and tissue mechanoadaptation | 2020 |
| 230 | SONOBOTS | Acousto-Magnetic Micro/Nanorobots for Biomedical Applications | 2019 |
| 231 | Cenya | Ex vivo cell labelling for in vivo imaging applied to cell therapeutics | 2019 |
| 232 | CAESAR | Developing Therapeutic Antibodies for Pets | 2019 |
| 233 | MiChomAbs | Synthetic Mini-Chromosomes for Antibody Production | 2019 |
| 234 | TrojanDC | TrojanDC | 2019 |
| 235 | PEPPER | Industrial-scale plant-based protein production in a cell-free platform | 2019 |
| 236 | C-stemGMP | c-GMP compliance of C-stem, an IPSc based cell therapies production technology | 2019 |
| 237 | CardioProtectMI | A New Drug Therapy for the treatment of ST Elevated Myocardial Infarction | 2019 |
| 238 | MEISi | Druggable Small Molecule Inhibitor of MEIS Proteins | 2019 |
| 239 | MedPhab | Photonics Solutions at Pilot Scale for Accelerated Medical Device Development | 2020 |
| 240 | OBSERVE | Overcoming cellular barriers to therapeutic RNA delivery using extracellular vesicles | 2020 |
| 241 | DDREAMM | Dna Damage REsponse: Actionabilities, Maps and Mechanisms | 2020 |
| 242 | M6AQuantKit | Development and commercialization of kit for quantitative interrogation of a key RNA modification | 2020 |
| 243 | PureIgY | Towards the use of IgY antibodies as alternative therapeutics | 2020 |
| 244 | Controlling MAC | Structural basis of controlling the membrane attack complex | 2020 |
| 245 | ICE_PACK | Polymer Materials for Cryogenic Storage and Distribution of Biologics | 2020 |
| 246 | TACT | Targeted Anti-Cancer Therapies | 2020 |
| 247 | Cells in Matrix | Cells in Matrix – an innovative 3D model for R&D of Diabetes | 2020 |
| 248 | BioTempSense | Understanding the thermodynamic and mechanistic basis of a model biological temperature sensor | 2021 |
| 249 | MiNeMI | Micronnedle-assisted nanovector skin patch for immunomodulation of the inflammatory response upon occurrence of myocardial infarction injury (MiNeMi) | 2020 |
| 250 | BESG | Bioengineered exosomes based approaches for the effective treatment of non-small cell lung cancer | 2020 |
| 251 | ANTIBIOCLICKS | BioInspired Clicked Siderophore-Antibiotics | 2020 |
| 252 | Pept-AGE | Elucidating the molecular mechanisms of age-related muscle loss to inform Artificial Intelligence-based discovery of novel peptide therapeutics for sarcopenia. | 2020 |
| 253 | USOME | Advanced Analysis of Polymersome and Exosome Hybrids for Potential Application in Therapeutics and Diagnostics | 2020 |
| 254 | HYPERDIVERSE | Keys to evolutionary success: untangling drivers of hyperdiversification | 2020 |
| 255 | CiliaCircuits | Molecular Principles of Mammalian Axonemal Dynein Assembly | 2020 |
| 256 | BALTIC | Machine learning based analytics for bacteria cell cycle characterization using super resolution microscopy | 2020 |